학술논문
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial
Document Type
Article
Author
Source
In The Journal of Allergy and Clinical Immunology March 2020 145(3):877-884
Subject
Language
ISSN
0091-6749